Market Place
Sourcing Support
All News #Library
Biotech
Edesa Bio To Present Oral Showcase At Respiratory Innovation
31 Mar 2026 //
GLOBENEWSWIRE
Edesa Biotech Advances Vitiligo Program for Mid-2026 Enrollment
26 Mar 2026 //
GLOBENEWSWIRE
Edesa Bio Reports More Phase 3 Paridiprubart Study Success
24 Feb 2026 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
13 Feb 2026 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal Year 2025 Results
12 Dec 2025 //
GLOBENEWSWIRE
Edesa Biotech Announces Upcoming Conference Schedule
31 Oct 2025 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
14 May 2025 //
GLOBENEWSWIRE
Edesa Biotech at Bloom Burton Healthcare Investor Conference
28 Apr 2025 //
GLOBENEWSWIRE
Edesa Biotech Announces Chief Financial Officer Transition
04 Apr 2025 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
14 Feb 2025 //
GLOBENEWSWIRE
Edesa Biotech Closes $15M Private Placement Priced At-the-Market
13 Feb 2025 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal Year 2024 Results
13 Dec 2024 //
GLOBENEWSWIRE
Edesa Biotech’s Founder Makes Strategic Investment in the Company
31 Oct 2024 //
GLOBENEWSWIRE
Edesa Biotech Announces Upcoming Conference Schedule
21 Oct 2024 //
GLOBENEWSWIRE
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
09 Aug 2024 //
GLOBENEWSWIRE
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
16 Mar 2023 //
ACCESSWIRE
Health Canada grants approval for Edesa Biotech’s vitiligo therapy trial
02 Feb 2023 //
CLINICAL TRIALS ARENA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.